[Use of mitotane (o,p'-DDD) in adrenal cortex hyperfunction].
作者信息
Kasperlik-Załuska A, Migdalska B
出版信息
Endokrynol Pol. 1982;33(1-3):99-104.
PMID:7183447
Abstract
摘要
相似文献
1
[Use of mitotane (o,p'-DDD) in adrenal cortex hyperfunction].
Endokrynol Pol. 1982;33(1-3):99-104.
2
[The effects of o,p'-DDD on human adrenal steroid synthesis].[邻对二氯二苯二氯乙烷对人体肾上腺类固醇合成的影响]
Nihon Naibunpi Gakkai Zasshi. 1984 Jul 20;60(7):852-71. doi: 10.1507/endocrine1927.60.7_852.
3
4
Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimide.采用邻对滴滴滴（o,p'-DDD）与氨鲁米特联合治疗肾上腺皮质癌。
Postgrad Med J. 1975 Jan;51(591):35-7. doi: 10.1136/pgmj.51.591.35.
5
[Cancer of the adrenal cortex treated by O,P"-DDD (author's transl)].
Acta Chir Belg. 1980 Jul-Aug;79(4):299-302.
6
Significant regression of the tumor combined with the high level of plasma cortisol by low-dose administration of O, p'-DDD in a case with Cushing's syndrome caused by adrenocortical carcinoma.
Tohoku J Exp Med. 1986 Dec;150(4):407-15. doi: 10.1620/tjem.150.407.
7
[O.p. DDD (lysodren) in treatment of adrenal cortex hyperfunction in childhood].
Kinderarztl Prax. 1981 Aug;49(8):436-41.
8
o,p'--DDD and adrenal carcinoma.
Ir J Med Sci. 1978 Dec;147(12):437-40. doi: 10.1007/BF02939448.
9
Clinical results of the use of mitotane for adrenocortical carcinoma.米托坦用于肾上腺皮质癌的临床疗效
Braz J Med Biol Res. 2000 Oct;33(10):1191-6. doi: 10.1590/s0100-879x2000001000008.
10
Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?评论——低剂量米托坦（邻，对'-滴滴滴）作为肾上腺皮质癌辅助治疗有作用吗？
J Clin Endocrinol Metab. 1999 Apr;84(4):1488-9. doi: 10.1210/jcem.84.4.5625-3.
Zotero 插件